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Case Report
Myoepithelial Carcinoma of Soft
Tissue With an EWSR1-KLF15 Gene
Fusion in an Infant
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Abstract
Overall, neonatal cancer is uncommon. Because of its rarity and heterogeneity, diagnosis can be challenging. We report a
unique case of a myoepithelial carcinoma in a 7 week old girl. Molecular diagnostic workup revealed a EWSR1-KLF15 gene fusion
which was previously described in only six cases of myoepithelial tumors so far. All cases occurred in children and adolescents.
To our knowledge, this is the first report of a congenital EWSR1-KLF15 fusion positive myoepithelial tumor in an infant.
Keywords
myoepithelial tumor soft tissue, EWSR1, KLF15, pediatric tumor, neonatal cancer
Introduction
Cancer in newborns and infants is very rare and accounts
for about 2% of all childhood cancers. Approximately one
in 12 500 to 27 500 live births is affected. Compared to
cancer in later childhood, neonatal cancer differs in inci-
dence, histological subtypes, clinical behavior, anatomical
site and therapy.1 The most common congenital tumors
are teratoma and neuroblastoma, though other tumor
types such as soft tissue sarcomas, leukemia, kidney and
brain tumors may also occur. Soft tissue tumors comprise
8–10% of neonatal tumors. Malignant soft tissue tumors
in this age group are mostly rhabdomyosarcoma, infantile
fibrosarcoma, rhabdoid tumors and others, some of them
associated with characteristic genetic alterations.2 Due to
the rarity, the broad spectrum of subtypes and often lim-
ited availability of biopsy material, pathological diagnos-
tics can be a challenge.3 We report a female infant with an
intramuscular myoepithelial carcinoma of the right shoul-
der in which an EWSR1-KLF15 gene fusion was detected.
Case Report
Clinical History
A 7-week-old, female baby presented with an indolent
palpable mass ventral to the right shoulder, which had
been growing rapidly since birth. Diagnostic imaging
including sonography and MRI revealed an extramuscu-
lar tumor of 25mm diameter, which was localized anteri-
or of the coracoid processus and below the pectoralis
major. The lesion was characterized by contrast enhance-
ment and was not clearly demarcated. Core-needle biopsy
showed a heterogeneous, partially necrotic tumor with a
solid and trabecular growth pattern composed of epithe-
lioid cells exhibiting nuclear atypia (Figure 1).
Neuroblastoma, rhabdomyosarcoma and infantile fibro-
sarcoma could be ruled out by immunohistochemistry
and FISH for ETV6 rearrangement. INI1 expression
was retained. CD99 showed a heterogenous expression
pattern. Due to foci of extracellular matrix (Figure 1
(C)) and co-expression of cytokeratin (AE1/AE3), S100
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and calponin (Figure 2), a myoepithelial tumor was sus-
pected. FISH with an EWSR1 Breakapart probe showed
an abnormal finding with loss of one 30EWSR1 signal in
>80% of cells (Figure 2). NGS based molecular workup
(Archer FusionPlex Sarcoma Panel) revealed an EWSR1-
KLF15 gene fusion (Figure 3). Necrotic foci, a high
proliferation rate (50% in a mib1 staining) and nuclear
atypia were worrisome for a malignant behavior.
Therefore, the diagnosis of a myoepithelial carcinoma
(malignant myoepithelial tumor) was established.
Staging showed no evidence of metastases. Neoadjuvant
chemotherapy was initiated according to the protocol
Figure 1. Histologic components of the MET. A, Epithelioid cells with nuclear atypia and discernible nucleoli. B, Ovoid to spindle cell
morphology. C, Cords of epithelioid cells embedded in a myxoid stroma. D, Dense population of small blue round cells.
Figure 2. Immunophenotype: Strong S-100 expression. Heterogenous cytokeratin (AE1/AE3) expression. Homogenous Calponin
expression. EWSR1 break apart FISH showing an abnormal finding with loss of one 3’EWSR1 signal.
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proposed in the TREP project: ifosfamide, cisplatin, and
etoposide (ICpE) for 4 cycles.4 Following chemotherapy,
the patient underwent tumor resection (Figure 4).
Histology showed a completely viable tumor without
response to therapy. Adjuvant chemotherapy was
switched to 3 cycles of Ifosfamid, Vincristin and
Etoposide. Nine months after chemotherapy a local
relapse cranial of the scar occurred. The lesion was
resected again. Histopathology confirmed relapse of a
8mm tumor, which was completely resected with 6–
22mm safety margins. The karyotype confirmed the
previous molecular findings of an EWSR1-KLF15 gene
fusion (Figure 3). Surgery was followed by proton thera-
py with 59.4 Gy(RBE). The girl is currently disease-free
two years after therapy.
Discussion
Myoepithelial tumors (MET) are rare in neonates and
infants. In the largest case series of 29 pediatric MET,
only four occurred in children younger than one year.5
Approximately 20% arise in the pediatric population,
Figure 3. A, Karyogram representing the 10 metaphases analyzed that contained an unbalanced translocation between chromosome 3 and 22
leading to loss of 3q andpartial lossof 22q.The karyotypewasdescribed as45,XX,der(3)(3pter!3q11.2::22q11.1!22q11.1::22q12.2),22 [10].
The circled chromosome 3 shows the normal copy on the left and the derivative chromosome on the right. The circled chromosome
22 shows the normal copy. B. Intron-exon structures of the EWSR1 and KLF15-transcripts as well as of the EWSR1-KLF15 fusion
transcript described in the text. Boxes with numbers represent exons, lines represent introns and arrows indicate the direction of
transcription. C, The sequence of a sample read containing the EWSR1-KLF15-fusion is displayed along with the in-silico translated
amino acid sequence. The part of the read that originated from Exon 8 of EWSR1 is coloured blue. The part of the read that originated
from Exon 2 of KLF15 is coloured red. The 5’-untranslated region (UTR) of KLF15 is coloured dark red, whereas the coding sequence
(CDS) of KLF15 appears light red. The fusion is in-frame.
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although the age range is very broad. They are equally
distributed between females and males.6,7
MET, also known as myoepitheliomas or mixed
tumors, were originally described in salivary glands,
but they can also arise in soft tissues and less frequently
in bone and visceral organs where the cell of origin to
date remains unknown.6,8,9 Although most of them are
benign, some MET show a malignant clinical course.
They are also called myoepithelial carcinomas and
affect children more often than adults.5
MET are characterized by a broad range of cytolog-
ical and architectural heterogeneity. Macroscopically, a
multinodular or lobular appearance may be evident.
Frequently, the tumor cells are epithelioid, but round
or spindle cell morphologies have also been observed.
They may be embedded in an extracellular matrix
(myxoid, hyalinized or chondroid). However, they all
have in common a distinctive, but not specific immuno-
phenotype with co-expression of epithelial markers
(cytokeratins, EMA), calponin and S100. 6,10 SOX10
might also be helpful in the immunohistochemical
workup.11 As mentioned before, some MET are malig-
nant. Various histological criteria such as necrosis,
mitotic rate or atypia were evaluated as indicators of
an aggressive behavior. However, only the presence of
nuclear atypia with discernible nucleoli has been
reported as reliable criterion for malignancy so far.6
In contrast to their counterparts in the salivary
glands, MET of soft tissue share a different molecular
phenotype. In almost half of the cases, EWSR1 rear-
rangements can be detected. A large number of fusion
partners are described so far, e.g. POU5F1, PBX1,
ZNF44, ATF1, PBX3, KLF15 and KLF17. 8,12
Alternative molecular aberrations are less frequent and
include homozygous deletion of the SMARCB1 gene13,
FUS12 and PLAG114 rearrangements.
The EWSR1-KLF15 gene fusion is very rare in MET
and was first described in two renal myoepithelial carci-
nomas. The patients were two girls, 4 and 6 years old.
Both presented with a huge kidney mass and lung metas-
tases.15 Another EWSR1-KLF15 positive myoepithelial
tumor was reported in the parotid of a 20-year-old
female patient. At the time of diagnosis, pulmonary
metastases were already present.16 Recently, an intracar-
diac MET with EWSR1-KLF15 gene fusion in a 4-
month-old male infant was published. After resection
the patient had a local relapse and developed brain
metastasis.17 In the very latest case series, two more
cases with EWSR1-KLF15 gene fusion were described:
One case was a thigh mass in a 7-year-old male patient.
The second developed in the urinary bladder of a 12
year-old female.12 All cases in the literature have certain
similarities with our case. First, they show a heteroge-
neous morphology with evidence of an undifferentiated
round cell component. Second, all cases occurred in chil-
dren and adolescents. Third, some of them share features
of malignant behavior. Four of them manifested
with metastases at the time of diagnosis. One showed
an aggressive round cell morphology. Only the
tumor in the urinary bladder was reported as benign.
The information about the so far reported ESWR1-
KLF15 fusion positive myoepithelial tumors are summa-
rized in Table 1.
Since no robust criteria for assessing tumor behavior
have yet been established, other parameters would be
desirable in this respect. It would be interesting to
know whether the different gene fusions could provide
insight on the biologic behavior of tumor. Recently,
Suurmeijer et al. evaluated possible associations between
translocation subtypes and clinicopathologic and mor-
phologic features in a cohort of 66 fusion positive MET.
Indeed, they found some emerging genotype-phenotype
Figure 4. Macroscopic appearance of the resected tumor after chemotherapy: Infiltrative margins and a lobular growth pattern.











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































correlations. In particular, the rare myoepithelial
tumors with EWSR1-KLF15 gene fusions seem to be
characterized by an undifferentiated (small blue) round
cell component, which might explain a more aggressive
clinical course.12
Due to their broad heterogeneity and overlapping
morphology to other soft tissue tumors, the diagnosis
of MET can be a challenge. Depending on the dominant
cell component, several differential diagnosis should be
considered: For example, epithelioid cells are typical for
epithelioid sarcoma, (extrarenal) rhabdoid tumor, epi-
thelioid malignant peripheral nerve sheath tumor and
sclerosing epithelioid fibrosarcoma. The latter shows
additionally not only a fibrotic stroma, but also
EWSR1 rearrangements, which are also characteristic
for MET. However, SEF is strongly MUC4 positive
and has a different fusion partner (CREB3L1 or
CREB3L2). The first three mentioned tumors with epi-
thelioid morphology are also characterized by loss of
INI1 expression, which can also be found in a subset
of MET, as mentioned above. In addition, they express
S100 (epithelioid MPNST) and cytokeratin (epithelioid
sarcoma), but none of them should show a co-expression
of S100 and cytokeratin, In addition, both do not fre-
quently occur in the pediatric population.
The undifferentiated round cell component opens the
broad differential diagnosis of round cell sarcomas
(Ewing sarcoma, Ewing-like sarcoma, desmoplastic
round cell tumor, undifferentiated synovial sarcoma,
etc), whereby the detailed discussion of each entity
would go beyond the scope of this article. However, it
should be stressed how important a molecular workup
is, since many round-cell sarcomas show EWSR1 rear-
rangements. Hence, the fusion partners differ from those
of MET. For completeness, extraskeletal myxoid chon-
drosarcoma (EMC) should also be mentioned. It is prob-
ably one of the closest mimics due to the strands of
round to oval cells embedded in myxoid stroma.
Furthermore, EMC may also show an EWSR1 rear-
rangement, but the typical fusion partner is NR4A3.
However, only rare cases have been reported in children.
In conclusion, we report a rare MET of soft tissue with
malignant features in a female infant. The molecular
workup showed a rare EWSR1-KLF15 gene fusion, which
supported the diagnosis. The girl is in complete remission
after surgery and radiotherapy of the tumor relapse.
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